Zynex Sets Second Quarter 2024 Earnings Call
Are Investors Undervaluing Zynex, Inc. (NASDAQ:ZYXI) By 36%?
Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces
All You Need to Know About Zynex (ZYXI) Rating Upgrade to Buy
RBC Capital Reiterates Outperform on Zynex, Maintains $15 Price Target
Zynex to Participate in Fireside Chat With RBC Capital Markets on Thursday, June 13, 2024
Why Zynex, Inc. (NASDAQ:ZYXI) Looks Like A Quality Company
Should Value Investors Buy Zynex (ZYXI) Stock?
Zynex (ZYXI) Is an Incredible Growth Stock: 3 Reasons Why
Zynex to Present at the RBC Capital Markets Global Healthcare Conference
3 Reasons Growth Investors Will Love Zynex (ZYXI)
Zynex Executives Recognized Among Top 25 in Medical Technology
We Think You Can Look Beyond Zynex's (NASDAQ:ZYXI) Lackluster Earnings
Catalyst Watch: Disney Earnings, Apple iPad Event and Fed Speakers Back on the Circuit
Zynex Inc (ZYXI) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Seizing ...
Zynex, Inc. (NASDAQ:ZYXI) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Exelixis (EXEL) and Zynex (ZYXI)
RBC Capital Reaffirms Their Buy Rating on Zynex (ZYXI)
Express News | HC Wainwright & Co. Reiterates Buy on Zynex, Maintains $21 Price Target
Zynex Analyst Ratings